Home › Funds › Invenomic Capital Management LP › VTRS

Invenomic Capital Management LP position in VTRS

VIATRIS INC · Health Care

Invenomic Capital Management LP reported holding 1,738,790 shares of VTRS (VIATRIS INC) in its Q2 2026 13F filing — a position valued at US$27.6M, representing 1.65% of its reported portfolio and ranking #18 among its reported holdings. Invenomic Capital Management LP has disclosed VTRS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.74M sh
Reported value held$27.61M
Portfolio Weight1.65%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's VTRS position evolved

Invenomic Capital Management LP first disclosed a stake in VTRS in Q3 2023 at 6,952,645 shares (US$68.6M). The position peaked in Q4 2025 at 5,593,608 shares, worth US$69.6M. Across 12 filings, Invenomic Capital Management LP increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,738,790 shares valued at US$27.6M — a reduction of -1,490,322 shares quarter over quarter.. Notable position changes include a 97% increase in Q1 2025 (shares rose 3% over the following quarter), a 42% trim in Q1 2026 (shares rose 18% over the following quarter), a 46% trim in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.95M $68.55M New
Q4 2023 5.81M $62.95M Reduce
Q1 2024 3.95M $47.19M Reduce
Q2 2024 4.29M $45.61M Add
Q3 2024 3.76M $43.65M Reduce
Q4 2024 3.26M $40.59M Reduce
Q1 2025 6.44M $56.06M Add
Q2 2025 4.64M $41.46M Reduce
Q3 2025 5.41M $53.59M Add
Q4 2025 5.59M $69.64M Add
Q1 2026 3.23M $43.63M Reduce
Q2 2026 1.74M $27.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VTRS and 13F data

VTRS (VIATRIS INC) is a Health Care company. 34 other funds we track also report a position in VTRS — the largest reported positions include DAVIS SELECTED ADVISERS (US$1.19B), Rubric Capital Management LP (US$542.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$320.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VTRS

All VTRS fund holders →

FAQ

How long has Invenomic Capital Management LP held VTRS?

Invenomic Capital Management LP has disclosed VTRS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Invenomic Capital Management LP's current position in VTRS?

As of Q2 2026, Invenomic Capital Management LP holds 1.74M shares of VTRS (VIATRIS INC), valued at $27.61M, representing 1.65% of its reported portfolio and ranking #18.

Has Invenomic Capital Management LP been buying or selling VTRS?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP reduced its position in VTRS. The position peaked in Q4 2025 at 5.59M shares.

Which other funds hold VTRS?

Other major institutional holders of VTRS include DAVIS SELECTED ADVISERS, Rubric Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.